Results 21 to 30 of about 67,556 (218)

Poor long-term outcomes for cryptococcal meningitis in rural South Africa. [PDF]

open access: yes, 2011
OBJECTIVES: To explore linkage to and retention in HIV care after an episode of cryptococcal meningitis (CM) in rural South Africa. Design. A retrospective case series of adult individuals (> or = 16 years old) with laboratory-confirmed CM from January -
Newell, Marie-Louise   +7 more
core   +1 more source

Cost effectiveness of cryptococcal antigen screening as a strategy to prevent HIV-associated cryptococcal meningitis in South Africa. [PDF]

open access: yes, 2013
OBJECTIVES: Cryptococcal meningitis (CM)-related mortality may be prevented by screening patients for sub-clinical cryptococcal antigenaemia (CRAG) at antiretroviral-therapy (ART) initiation and pre-emptively treating those testing positive.
Thomas S Harrison   +32 more
core   +1 more source

Genotypic diversity is associated with clinical outcome and phenotype in cryptococcal meningitis across Southern Africa [PDF]

open access: yes, 2015
This work was supported by Wellcome Trust (UK) (www.wellcome.ac.uk) awards to TB (WT069991), GM (WT098316), and JNJ (WT081794); Medical Research Council (MRC UK) (www.mrc.ac.uk) awards to MCF (K000373/1), RCM (G0601171), TSH (G1002327); European Research
Fisher, Matthew C   +64 more
core   +1 more source

Cryptococcal Meningitis Developing in a Patient with Neurosarcoidosis [PDF]

open access: yes, 2023
Cryptococcal meningitis is a critical disease that occasionally involves immunosuppressed patients. We herein report a 79-year-old Japanese man who received low-dose prednisolone therapy for neurosarcoidosis and panhypopituitarism.
Shinnosuke Fukushima   +11 more
core   +1 more source

Utility of clinical assessment, imaging, and cryptococcal antigen titer to predict AIDS-related complicated forms of cryptococcal meningitis

open access: yesAIDS Research and Therapy, 2010
Background This study aimed to evaluate the prevalence and predictors of AIDS-related complicated cryptococcal meningitis. The outcome was complicated cryptococcal meningitis: prolonged (≥ 14 days) altered mental status, persistent (≥ 14 days) focal ...
Kandel Sean   +5 more
doaj   +1 more source

Cryptococcal meningitis: improving access to essential antifungal medicines in resource-poor countries [PDF]

open access: yes, 2013
Cryptococcal meningitis is the leading cause of adult meningitis in sub-Saharan Africa, and contributes up to 20% of AIDS-related mortality in low-income and middle-income countries every year.
Chiller, Tom   +8 more
core   +1 more source

Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3

open access: yesBMC Infectious Diseases, 2020
Background Cryptococcal antigen (CrAg) screening with fluconazole prophylaxis has been shown to prevent cryptococcal meningitis and mortality for people living with HIV (PLWH) with CD4 
James Wykowski   +6 more
doaj   +1 more source

“False negative” CSF cryptococcal antigen with clinical meningitis: Case reports and review of literature

open access: yesMedical Mycology Case Reports, 2020
There is an increasing recognition of patients presenting with cryptococcal meningitis despite having a negative CSF cryptococcal antigen (CrAg). In this report, we describe three cases of patients with advanced immunosuppression who presented to ...
Morris K. Rutakingirwa   +2 more
doaj   +1 more source

Low CD4 count plus coma predicts cryptococcal meningitis in Tanzania

open access: yesBMC Infectious Diseases, 2007
Background Largely due to the lack of diagnostic reagents, the prevalence and clinical presentation of cryptococcal meningitis in Tanzania is poorly understood. This in turn is limiting the impact of increased fluconazole availability.
Mueller Andreas   +6 more
doaj   +1 more source

Cryptococcal meningitis in HIV-infected patients: a longitudinal study in Cambodia. [PDF]

open access: yes, 2010
To describe the frequency of diagnosis of cryptococcosis among HIV-infected patients in Phnom Penh, Cambodia, at programme entry, to investigate associated risk factors, and to determine the incidence of cryptococcal ...
Ngeth Chanchhaya   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy